Asia Pacific Clinical Nutrition Market (2020 to 2026) – Trend Forecast and Growth Opportunities – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Asia Pacific Clinical Nutrition Market 2020-2026 by Substrate, Administration Route (Oral or Enteral, Parenteral), End User, Therapeutic Area, Healthcare Setting, Distribution Channel, and Country: Trend Forecast and Growth Opportunity” report has been added to ResearchAndMarkets.com’s offering.

Asia Pacific clinical nutrition market will grow by 8.27% annually with a total addressable market cap of $180.67 billion over 2020-2026 driven by increasing incidence of malnutrition, the rising prevalence of communicable and non-communicable chronic diseases amid COVID-19 pandemic.

The report is based on a comprehensive research of the entire Asia Pacific clinical nutrition market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2026 with 2019 as the base year.

Key Players

• Abbott Nutrition
• B Braun Melsungen Ag
• BASF SE
• Baxter International Inc.
• Claris Lifesciences Ltd.
• Fresenius Kabi Ag
• Lonza Group AG
• Nestle Health Science
• Nutricia Ltd
• Perrigo Company Plc

In-depth qualitative analyses include identification and investigation of the following aspects:

• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Five Forces

The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Asia Pacific clinical nutrition market in every aspect of the classification from perspectives of Substrate, Administration Route, End User, Therapeutic Area, Healthcare Setting, Distribution Channel, and Country.

For each country, detailed analysis and data for annual revenue are available for 2019-2026. The breakdown of key national markets by Administration Route, End User, and Therapeutic Area over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Specifically, potential risks associated with investing in Asia Pacific clinical nutrition market are assayed quantitatively and qualitatively through a Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.

Key Topics Covered:

1 Introduction

2 Market Overview and Dynamics

2.1 Market Size and Forecast

2.1.1 Impact of COVID-19 on World Economy

2.1.2 Impact of COVID-19 on the Market

2.2 Major Growth Drivers

2.3 Market Restraints and Challenges

2.4 Emerging Opportunities and Market Trends

2.5 Porter’s Five Forces Analysis

3 Segmentation of Asia Pacific Market by Substrate

3.1 Market Overview by Substrate

3.2 Carbohydrates

3.3 Lipids

3.4 Proteins & Amino Acids

3.5 Water & Electrolyte

3.6 Dietary Fiber

3.7 Antioxidants

3.8 Other Substrates

4 Segmentation of Asia Pacific Market by Administration Route

4.1 Market Overview by Administration Route

4.2 Oral or Enteral Administration

4.2.1 Oral Nutrition Supplements

4.2.2 Tube Feeding

4.3 Parenteral Administration

4.3.1 Supplemental Parenteral Nutrition

4.3.2 Total Parenteral Nutrition

4.3.3 All-in-One System

4.3.4 Multiple Bottle System

5 Segmentation of Asia Pacific Market by End User

5.1 Market Overview by End User

5.2 Infant

5.3 Children

5.4 Adult

5.5 Geriatrics

6 Segmentation of Asia Pacific Market by Therapeutic Area

6.1 Market Overview by Therapeutic Area

6.2 Malnutrition

6.3 Metabolic Disorders

6.4 Gastrointestinal Disorders

6.5 Cancer

6.6 Neurology

6.7 Renal Diseases

6.8 Respiratory Diseases

6.9 Other Therapeutic Areas

7 Segmentation of Asia Pacific Market by Healthcare Setting

7.1 Market Overview by Healthcare Setting

7.2 Hospitals

7.3 Long-term Care Facilities (LTC)

7.4 Homecare

7.5 Inpatient Rehabilitation Facilities

7.6 Other Healthcare Settings

8 Segmentation of Asia Pacific Market by Distribution Channel

8.1 Market Overview by Distribution Channel

8.2 Institutional Sales

8.3 Supermarkets & Hypermarkets

8.4 Pharmacies

8.5 Drug Stores

8.6 Online Channels

8.7 Other Distribution Channels

9 Asia-Pacific Market 2019-2026 by Country

9.1 Overview of Asia-Pacific Market

9.2 China

9.3 Japan

9.4 India

9.5 Australia

9.6 South Korea

9.7 Rest of APAC Region

10 Competitive Landscape

10.1 Overview of Key Vendors

10.2 New Product Launch, Partnership, Investment, and M&A

10.3 Company Profiles

11 Investing in Asia Pacific Market: Risk Assessment and Management

11.1 Risk Evaluation of Asia Pacific Market

11.2 Critical Success Factors (CSFs)

For more information about this report visit https://www.researchandmarkets.com/r/q9qgzy

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900